Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kate Behm & Prue Morgan. (2018) The effect of symptom-controlling medication on gait outcomes in people with multiple sclerosis: a systematic review. Disability and Rehabilitation 40:15, pages 1733-1744.
Read now
Read now
Dirk Deleu, Boulenouar Mesraoua, Hisham El Khider, Beatriz Canibano, Gayane Melikyan, Hassan Al Hail, Noha Mhjob, Anjushri Bhagat, Faiza Ibrahim & Yolande Hanssens. (2017) Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from Qatar. Current Medical Research and Opinion 33:3, pages 439-458.
Read now
Read now
Jacobo Cambil-Martín, Noelia Galiano-Castillo, Elena Muñoz-Hellín, Lourdes Díaz-Rodríguez, Sofía Laguarta-Val, César Fernández-de-las-Peñas & Manuel Arroyo-Morales. (2016) Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study. Nutritional Neuroscience 19:2, pages 79-85.
Read now
Read now
B. Yamout, R. Alroughani, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, M. Sahraian, S. Khoury, Z. Alkawi, S. Koussa, M. Zakaria, J. Al Khaburi, T. Alsaadi & S. Bohlega. (2015) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS). Current Medical Research and Opinion 31:7, pages 1349-1361.
Read now
Read now
Articles from other publishers (14)
Juan de Dios Pérez-Bruzón, César Fernández-de-las-Peñas, Joshua A. Cleland, Gustavo Plaza-Manzano & Ricardo Ortega-Santiago. (2022) Effects of neurodynamic interventions on pain sensitivity and function in patients with multiple sclerosis: a randomized clinical trial. Physiotherapy 115, pages 36-45.
Crossref
Crossref
Rui‐Xin Deng, Ye‐Jun Wu, Lan‐Ping Xu, Kai‐Yan Liu, Xiao‐Jun Huang & Xiao‐Hui Zhang. (2021) Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies. American Journal of Hematology 96:11, pages 1407-1419.
Crossref
Crossref
Marisa P. McGinley & Jeffrey A. Cohen. 2021. Neuroimmunology. Neuroimmunology
75
87
.
B. Yamout, M. Sahraian, S. Bohlega, M. Al-Jumah, R. Goueider, M. Dahdaleh, J. Inshasi, S. Hashem, I. Alsharoqi, S. Khoury, M Alkhawajah, S. Koussa, J. Al Khaburi, A. Almahdawi, T. Alsaadi, E. Slassi, S Daodi, M. Zakaria & R. Alroughani. (2020) Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines. Multiple Sclerosis and Related Disorders 37, pages 101459.
Crossref
Crossref
Jianzhen Shi, Xiaohui Wu & Yanmei Chen. (2019) Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis. PLOS ONE 14:9, pages e0222288.
Crossref
Crossref
Xiao-hui Zhang, Xin Zhao, Chen-cong Wang, Wei Han, Huan Chen, Yu-hong Chen, Feng-rong Wang, Jing-zhi Wang, Yuan-yuan Zhang, Xiao-dong Mo, Yao Chen, Yu Wang, Hai-xia Fu, Ying-jun Chang, Lan-ping Xu, Kai-yan Liu & Xiao-jun Huang. (2018) IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCT. Annals of Hematology 97:8, pages 1399-1406.
Crossref
Crossref
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman, Kazuo Fujihara, Steven L Galetta, Hans Peter Hartung, Ludwig Kappos, Fred D Lublin, Ruth Ann Marrie, Aaron E Miller, David H Miller, Xavier Montalban, Ellen M Mowry, Per Soelberg Sorensen, Mar Tintoré, Anthony L Traboulsee, Maria Trojano, Bernard M J Uitdehaag, Sandra Vukusic, Emmanuelle Waubant, Brian G Weinshenker, Stephen C Reingold & Jeffrey A Cohen. (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology 17:2, pages 162-173.
Crossref
Crossref
Raed Alroughani, Samar Farouk Ahmed, Raed Behbehani & Jasem Al-Hashel. (2017) The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study. Pediatric Neurology 70, pages 56-60.
Crossref
Crossref
Jiafeng Chen, Chunkui Zhou, Lijun Zhu, Xiuli Yan, Yonghong Wang, Xin Chen & Shaokuan Fang. (2017) Magnetic resonance diffusion tensor imaging for occult lesion detection in multiple sclerosis. Experimental and Therapeutic Medicine 13:1, pages 91-96.
Crossref
Crossref
Jose Eustasio Meca‐Lallana, Rocío Hernández‐Clares & Ester Carreón‐Guarnizo. (2015) Spasticity in multiple sclerosis and role of glatiramer acetate treatment. Brain and Behavior 5:9.
Crossref
Crossref
J. J. Fernández-Muñoz, A. Morón-Verdasco, M. Cigarán-Méndez, E. Muñoz-Hellín, M. Pérez-de-Heredia-Torres & C. Fernández-de-las-Peñas. (2015) Disability, quality of life, personality, cognitive and psychological variables associated with fatigue in patients with multiple sclerosis. Acta Neurologica Scandinavica 132:2, pages 118-124.
Crossref
Crossref
César Fernández-de-las-Peñas, Ricardo Ortega-Santiago, Rosa Ortíz-Gutiérrez, Ana B. Caminero, Jaime Salom-Moreno & Lars Arendt-Nielsen. (2015) Widespread Pressure Pain Hypersensitivity in Patients With Multiple Sclerosis With and Without Pain as Sign of Central Sensitization. The Clinical Journal of Pain 31:1, pages 66-72.
Crossref
Crossref
Shao-can Tang, Xiao-hua Fan, Qing-min Pan, Qiang-san Sun & Yu Liu. (2015) Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis. Journal of the Neurological Sciences 348:1-2, pages 174-180.
Crossref
Crossref
Jasem AL-Hashel, Samar F. Ahmed, Raed Behbehani & Raed Alroughani. (2014) Real-World Use of Fingolimod in Patients with Relapsing Remitting Multiple Sclerosis: A Retrospective Study Using the National Multiple Sclerosis Registry in Kuwait. CNS Drugs 28:9, pages 817-824.
Crossref
Crossref